The Efficacy and Safety of Edaravone Dexborneol Sequential Therapy in the Treatment of Patients With AIS
Clinical trial NCT06176781 · UNKNOWN
Trial details
- NCT number
- NCT06176781
- Sponsor
- Simcere Pharmaceutical Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-28
- Primary completion
- 2025-03-28
- Enrollment
- 880
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.